Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06775106 · ClinicalTrials.gov registry record

Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections

A clinical trial of Critical Illness and Pulmonary Disease, sponsored by Oregon Health and Science University.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT06775106 is a study of Critical Illness and Pulmonary Disease that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 100 participants, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06775106, a study of Critical Illness and Pulmonary Disease, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.

Interventions

  • OTHER There is no intervention in this observational study

Study Locations (1)

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-11-30
Est. Completion 2026-12-31

What the Registry Record Tells You About NCT06775106

The ClinicalTrials.gov registry entry for NCT06775106 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention in this observational study is the first listed.

NCT06775106 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06775106 about?

NCT06775106 is a clinical study titled "Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections". This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.

What is the current status of trial NCT06775106?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-11-30. Estimated completion is 2026-12-31.

What conditions does trial NCT06775106 study?

This clinical trial studies the following conditions: Critical Illness, Pulmonary Disease.

What interventions are being tested in trial NCT06775106?

The interventions under investigation include: There is no intervention in this observational study (OTHER).

Who is sponsoring clinical trial NCT06775106?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06775106 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.